NEW YORK (Genomeweb) - Epic Sciences announced today that it has completed a $52 million Series E financing.

The financing round was led by Blue Ox Healthcare Partners, with participation by Deerfield Management and Varian. Existing investors also participated, including Altos Capital Partners, Genomic Health, Domain Associates, VI Ventures, Alexandria Venture Investments, and Sabby Management.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.